Daria Lewis
Payments from drug & device makers
Across 1,002 payments — averaging $66.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$48K
- Johnson & Johnson$3K
- Otsuka America Pharmaceutical, Inc.$3K
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Neurocrine Biosciences, Inc.$2K
- plus $7K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 167 | $47,876 |
| Johnson & Johnson | 91 | $3,007 |
| Otsuka America Pharmaceutical, Inc. | 96 | $2,588 |
| AbbVie | 141 | $2,542 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 124 | $1,872 |
| Neurocrine Biosciences, Inc. | 71 | $1,768 |
| Vanda Pharmaceuticals Inc. | 71 | $1,604 |
| Teva Pharmaceuticals USA, Inc. | 48 | $963 |
| E.r. Squibb & Sons, L.L.C. | 18 | $668 |
| Supernus Pharmaceuticals, Inc. | 35 | $655 |
| Corium, LLC | 32 | $641 |
| Lundbeck LLC | 24 | $561 |
| Indivior Inc. | 17 | $353 |
| Axsome Therapeutics, Inc. | 11 | $291 |
| USWM, LLC | 12 | $223 |
| Sunovion Pharmaceuticals Inc. | 10 | $159 |
| Almatica Pharma LLC | 8 | $131 |
| Orexo US, Inc. | 5 | $77 |
| Eisai Inc. | 4 | $69 |
| Tris Pharma Inc | 3 | $49 |
| Noven Therapeutics, LLC | 3 | $46 |
| Luye Pharma (USA) Ltd. | 2 | $43 |
| Braeburn Inc. | 2 | $42 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Pfizer | 1 | $13 |
How this compares
$66,345 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Cary
- Amanda KellyCary$94K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.